📰 Patrick Lin News
Page 5 - Patrick Lin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Patrick Lin. Real-time updates on events, politics, business and more.
November 14, 2022
Mario Lopez is coming to Westfield Montgomery in Bethesda, Maryland for “Home for the Holidays” on Sunday from 11 a.m. to 1 p.m.
October 4, 2022
Cal Poly Ethics and Emerging Sciences group was awarded a grant of over $700,000 to study the impacts of artificial intelligence in kitchens.
October 3, 2022
Cal Poly is being given $700,000 in federal grants to study the impacts of artificial intelligence in the kitchen, the school announced Monday.
July 20, 2022
The huge growth in software creates a need for technologies that go beyond traditional monitoring. Observability promises to do just that.
July 14, 2022
From September 3, 2022 through April 23, 2023, the San José Museum of Art (SJMA) will present the first major touring museum exhibition of Los Angeles–based artist Kelly Akashi (born ...
May 5, 2022
05.05.2022 - HANOVER, MD, May 05, 2022 (GLOBE NEWSWIRE) - Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need ...
May 2, 2022
The Arts Partnership previews two arts events happening soon in the community.
April 2, 2022
Zacks Investment Research upgraded shares of Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) from a sell rating to a hold rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who […]
March 31, 2022
Wall Street brokerages expect Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) to post earnings per share of ($0.18) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Processa Pharmaceuticals’ earnings. Processa Pharmaceuticals reported earnings of ($0.90) per share in the same quarter last year, which indicates a positive year-over-year […]
March 26, 2022
Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. According to Zacks, “Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality […]